We present a cross-sectional analysis of the maturation and migratory properties of the memory CD8
Introduction
Chagas' disease, caused by the protozoan parasite Trypanosoma cruzi, is characterized by cardiac and digestive abnormalities, which develop in 20-30% of infected individuals many years after the acute infection has been controlled. Trypanosoma cruzi is an obligate intracellular parasite, which invades and replicates within a wide variety of mammalian cells. As with other intra-cytoplasmatic parasites, T. cruzi proteins released into the host cell cytosol are processed and presented on MHC-class I molecules, leading to the recognition of parasite components by CD8 + T cells (1, 2) . The important role of CD8 + T lymphocytes in resistance to T. cruzi has been demonstrated by studies showing the predominance of CD8 + T cell in inflammatory infiltrates in infected tissues (3) (4) (5) (6) , the ability of CD8 + T cells from chronic chagasic patients and infected mice to act as CTLs against T. cruziinfected cells (7) and the increased tissue parasite burden, the absence of inflammatory response and the rapid mortality of mice lacking CD8 + T cells (8, 9) .
Previous studies from our laboratories have shown that the frequency of IFN-c-producing memory CD8 + Tcells specific for T. cruzi-derived peptides is very low regardless of the clinical status but in patients with severe disease is essentially undetectable (10) . Moreover, the analysis of a wider range of T cell targets, by stimulation with a T. cruzi amastigote lysate, revealed a higher frequency of responders among patients with mild or no clinical disease and a low frequency of responders among those with the more severe form of the disease, indicating an inverse correlation between T. cruzi-specific T cell responses and disease severity. In spite of the large amount of data available on the characteristics of the immune response in Chagas' disease, the mechanisms involved in the maintenance of T. cruzi-specific memory T cell responses and their role in the transition from the asymptomatic phase to clinically manifest cardiomyopathy remains poorly understood.
Recently, based on the combined expression of CD27 and CD28, Appay et al. (11) ) that circulate to peripheral tissues and exhibit rapid effector function upon encounter with the antigen (12) .
Herein, we have examined the impact of chronic T. cruzi infection on the maturation and migratory properties of memory CD8 + T cells in relation to the severity of the heart disease in chronic chagasic subjects.
Methods

Selection of study population
Chronic chagasic subjects were recruited at the Instituto Nacional de Parasitología Dr. Mario Fatala Chabé n and at the Chagas disease Section, Cardiology Department, Hospital Interzonal General de Agudos Eva Peró n. Signed informed consent was obtained from all individuals prior to inclusion in the study. Trypanosoma cruzi infection was determined by a combination of indirect immunofluorescence assay, hemagglutination and ELISA tests, performed in the Diagnostic Department of the Instituto Nacional de Parasitología Dr. Mario Fatala Chabé n and in the Clinical Laboratory of Parasitology, Hospital Interzonal General de Agudos Eva Peró n. Subjects positive on at least two of these tests were considered to be infected. Subjects were evaluated clinically and grouped according to the Kuschnir grading system (13) . Group 0 (G0) included seropositive individuals exhibiting a normal electrocardiogram (ECG) and a normal chest X-ray, group 1 (G1) seropositive patients with a normal chest X-ray but abnormalities in the ECG, group 2 (G2) seropositive patients with ECG abnormalities and heart enlargement as determined by chest X-ray and group 3 (G3) seropositive patients with ECG abnormalities, heart enlargement and clinical or radiological evidence of heart failure. A total of 25 out of 92 patients had been previously treated with 5 mg benznidazole kg ÿ1 day ÿ1 for 30 days, at some point during adulthood. Benznidazole was provided by the Ministry of Health of Buenos Aires Province, and administered by the patient in ambulatory conditions ( Table 1) .
The control group consisted of age-matched Caucasian natives from Argentina who have always resided in nonendemic areas and were serologically negative for T. cruzi. Chagasic subjects and non-infected controls with hypertension, ischemic heart disease, cancer, HIV infection, syphilis, diabetes, arthritis or serious allergies were excluded from this study. The data on the number, sex and age of the subjects included in this study are summarized in Table 1 .
Collection of PBMCs
Approximately 50 ll blood was drawn from patients and control subjects by venipuncture into heparinized tubes (Vacutainer, Becton Dickinson, San Jose, CA, USA). PBMCs were isolated by density gradient centrifugation on lymphocyte separation medium (ICN, Ohio, OH, USA) and resuspended in RPMI-1640 (Mediatech, Herndon, VA, USA) supplemented with 10% heat-inactivated FCS (Hyclone Laboratories, Logan, UT, USA), 20 mM HEPES, 2 mM L-glutamine, 1 mM pyruvate, 0.1 mM non-essential amino acids, 50 U penicillin per 50 lg ml ÿ1 streptomycin and 50 lM 2-mercaptoethanol (complete RPMI). mAbs mAbs anti-CCR7-PE, anti-Ki-67-FITC and anti-CD28-allophycocyanin (APC) were purchased from BD Pharmingen (San Diego, CA, USA). Anti-IFN-c-PE or -FITC, anti-CD38 Tri-color (TC) and anti-CD8-APC-Cy7 were obtained from Caltag Laboratories (Burlingame, CA, USA). Other sources of mAbs were Serotec (Oxford, UK), anti-CD45RA-PE-Cy5; Bioscience (San Diego, CA, USA), anti-CD27-FITC, and Becton Dickinson, anti-CD8-PerCP.
Stimulation of PBMCs with T. cruzi-infected dendritic cells
Dendritic cell (DC)-enriched populations were generated from PBMCs of chronic chagasic subjects and non-infected individuals, as described by Ponsaerts et al. (14) . Briefly, 2 3 10 7 PBMCs per well were incubated in six-well plates at 37°C in 5% CO 2 atmosphere for 2 h, to allow monocytes to adhere. Non-adherent cells were then removed and frozen at ÿ80°C for later use, and the adherent cell fraction was cultured in serum-free AIM-V medium (GIBCO, Invitrogen, CA, USA) supplemented with 1000 U ml ÿ1 recombinant human granulocyte macrophage colony-stimulating factor (ID Labs Inc., Ontario, Canada) for 2 days. Afterward, the cells were harvested, washed and re-suspended in complete RPMI at 1 3 10 5 DCs ml ÿ1 . Two hundred microliters of the DC suspension was seeded per well in 48-well plates and cocultured with VERO cell culture-derived trypomastigotes (Brazil strain) at a parasite to DC ratio of 5 : 1 for 48 h. Then, free parasites in the supernatants were removed and frozen autologous monocyte-depleted PBMCs thawed and added to T. cruzi-infected DC cultures at a DC to autologous cell ratio of G0, seropositive individuals with normal ECG and chest X-rays; G1, seropositive patients with normal chest X-ray but abnormal ECG; G2, seropositive patients with abnormal ECG and heart enlargement on chest X-rays; G3, seropositive patients with abnormal ECG and heart enlargement on chest X-rays and clinical or radiological evidence of heart failure. a Number of patients previously treated for Trypanosoma cruzi infection. 
Apoptosis detection
Cell apoptosis was assessed by Annexin V staining with the flow cytometric apoptosis detection kit (BD Pharmingen, Becton Dickinson). A total of 2 million PBMCs ml ÿ1 were cultured with media alone for 20 h. Afterward, 1 3 10 6 cells were stained with anti-CD8 (PE) for 45 min at 4°C. After incubation, the cells were washed and re-suspended in binding buffer and stained with 5 ll of Annexin and 5 ll of propidium iodine for 15 min at room temperature in the dark. Afterward, 400 ll of binding buffer was added and the samples were run within 1 h. Data were acquired on a FACSCalibur (Becton Dickinson) flow cytometer. Acquired data were analyzed with Flowjo version 4.2 software.
Statistical analysis
Differences between groups were evaluated by analysis of variance followed by Bonferroni test for multiple comparison. A simple lineal regression test was used for trend analysis. Differences were considered statistically significant when P < 0.05.
Results
Maturation profile of T. cruzi-specific memory CD8 + T cells in chronic chagasic subjects
The previously reported (10) low frequency of IFN-c-producing memory CD8
+ T cells specific for T. cruzi in subjects with chronic T. cruzi infection prompted us to characterize T. cruzispecific responses using infected autologous DCs to enhance in vitro antigen presentation (15) . To assess the maturation status of responding T. cruzi-specific memory CD8 + T cells, we measured the expression of CD27 and CD28 surface markers on IFN-c-secreting CD8 + T cells stimulated with T. cruziinfected DCs. Confirming our previous observations, subjects in the G0 and G1 clinical groups were more likely to mount T. cruzi-specific IFN-c responses (16 of 19; 84%) than subjects classified as G2 and G3 (four of eight; 50%; Fig. 1 ). Interestingly, the T. cruzi-specific CD8 + T cell population was, on average, enriched in CD27 + CD28 + cells, characteristic of an early-differentiated phenotype in responding subjects, irrespective of clinical status (Fig. 2) .
Maturation profile of the total CD8
+ T cell compartment in PBMCs of chronic chagasic subjects
In the case of HIV infection, Appay et al. (16) had shown that the phenotype of the total CD8 + T cell compartment reflected well the phenotype of the HIV-specific T cells. Because of the relatively low frequency of T. cruzi-specific IFN-c-producing memory CD8
+ T cells and our previous failure to identify memory CD8 + T cells using MHC-tetramers (10), we evaluated the impact of T. cruzi infection on the total memory CD8 + T cell differentiation status, measuring the expression of CD27 and CD28 in peripheral CD45RA ÿ CD8 + (antigen experienced) T cells from 51 chronic chagasic subjects with different degrees of cardiac dysfunction. Seventeen non-chagasic subjects were used as controls. Although similar percentages of peripheral CD8 + CD45RA ÿ T cells were found in chagasic subjects and the controls (mean percentage 6 SD = 9.1 6 4.1 and 7.5 6 ÿ4.4, respectively), the pattern of CD27 and CD28 expression on the antigen-experienced CD8 + T cells was distinct in these two groups. In chagasic subjects, the percentages of CD27 + CD28 + cells were lower and the percentages of CD27 ÿ CD28 ÿ cells higher in the CD8 + CD45RA
ÿ T cell population relative to control subjects (Table 2) . Furthermore, as disease becomes more severe, a negative trend in the percentages of early-differentiated (CD27 + CD28 + ) (P < 0.0001) and a positive trend in the percentages of fully Table 2 ). The proportions of the CD27 + CD28 ÿ and CD27 ÿ CD28 + subsets do not change in any consistent way with disease severity. These findings suggest that the memory CD45RA ÿ CD8 + T cell compartment differentiates toward a more mature phenotype with increased severity of the disease in chronic T. cruzi infection.
The percentage of CD8 + CD45RA + T cell population, composed of naive and effector T cells, was similar in chronic chagasic subjects and uninfected controls (mean percentage 6 SD = 17.6 6 7.6 and 18.7 6 4.9, respectively). However, evaluation of the expression of CD27 and CD28 in CD8 + CD45RA + T cells showed significantly lower percentages of CD27 + CD28 + (naive) and higher percentages of CD27 16.1, respectively, P < 0.001; Fig. 3 ). However, no significant differences were observed in the percentages of effector and naive CD8 + T cells among the four clinical groupings within chronically infected individuals. The higher levels of effector CD8 + T cells were associated with a predominantly resting phenotype of the total CD8 + T cell compartment, as observed by the low expression of CD38 and Ki-67, markers for recently activated and proliferating T cells, respectively (data not shown). This distinctive phenotypic profile of chronic chagasic subjects indicates an association between chronic T. cruzi infection and a more mature phenotype of the total CD8 + T cell compartment.
Assessment of central and effector total memory CD8 + T cells in chronic chagasic subjects
Memory CD8 + T cells were further characterized for the expression of the CCR7 chemokine receptor associated with the homing of memory T cells to lymph nodes. The results of this analysis showed that the percentage of CD8 + CD45RA ÿ CCR7 ÿ (effector memory) T cells in G1 subject group was significantly higher (mean percentage 6 SD = 31.8 6 21.1; Fig. 4 ) than in the uninfected group (mean percentage 6 SD = 9.9 6 8.8, P < 0.05). In contrast, the percentage of CD8 + CD45RA ÿ CCR7 + (central memory) T cells in chagasic subjects is similar to the controls, and does not vary with respect to clinical group (Fig. 4) . These results show that the number of CD8 + T cells capable of rapid effector function is highest in subjects who are in the early stages of heart disease development, and is low and at control levels in subjects with more severe disease.
Levels of spontaneous apoptosis in the peripheral CD8 + T cell compartment
The low frequency of T. cruzi-specific IFN-c-secreting CD8 + T cells (10; Fig. 1 ) and the highly differentiated profile of the total memory CD8 + T cell compartment (Table 2) found in chronic chagasic subjects with the most severe clinical forms of the disease suggest that CD8 + T cells during persistent T. cruzi infection were being driven to senescence. To investigate this possibility, the level of Annexin V, a marker of apoptosis, was examined in CD8 + T cells from 23 chronic chagasic subjects and six uninfected controls. The results of this analysis showed higher levels of spontaneous apoptosis of CD8 + T cells in subjects with heart dysfunction as compared with asymptomatic subjects and uninfected controls (Fig. 5) , Data are expressed as the mean 6 SD of the percentage of CD8 + CD45RA ÿ T lymphocytes of each phenotype. *Negative trend P < 0.0001; **P < 0.0001 respect to the controls; ***positive trend P < 0.0001. consistent with a higher rate of terminally differentiated CD8 + T cells from patients with severe cardiac dysfunction.
Discussion
The primary clinical consequence of T. cruzi infection is a chronic cardiomyopathy which becomes manifest many years after the initial infection. There is a large body of data from human and animal model systems providing evidence for a strong connection between parasite persistence and the presence of disease (reviewed in [17] [18] [19] . It can be reasoned that an immune response of sufficient strength, sustained in time, and directed to the appropriate targets would efficiently control T. cruzi infection, preventing disease progression. Supporting the notion that the clinical disease status relates to the level of T. cruzi-specific T cell responses, we recently showed that subjects removed from the endemic area for longer than 20 years with advanced disease have significantly lower levels of IFN-c-secreting memory T cells specific for the parasite, compared with those with none or only modest disease symptoms (10) . In this study, we used autologous DCenriched populations infected with T. cruzi to stimulate PBMCs in order to improve antigen presentation and CD8 + T cell stimulation and the results of this analysis were consistent with those found with a parasite lysate as well as with peptides predicted to be targets of CD8 + T cell responses in T. cruzi infection (10, 36) .
The lower frequency of T. cruzi-specific CD8 + T cells observed in subjects with more severe disease supports a less efficient generation of memory CD8 + T cells or a more marked decline in memory T cell function over time in these individuals. Interestingly, a predominantly early-differentiation phenotype of T. cruzi-specific memory CD8 + T cells capable of rapid production of IFN-c was found in all clinical groups. This phenotypic profile of the CD8 + T cells responding to infected DCs contrasts with that of the total antigen-experienced memory CD8
+ T cell population in chronically infected subjects. In the latter, the number of early-differentiated memory (CD45RA ÿ CD27 + CD28 + ) CD8 + T cells is low in subjects with more severe disease, while the proportion of fully differentiated memory (CD45RA
T cells is high. This apparently disparate phenotype of the T. cruzi-specific, IFN-c-producing cells relative to the total T cell population may not be surprising, given that the T cells responding to T. cruzi with IFN-c production represent only a small fraction of the total CD8 + T cell compartment in chronically infected chagasic subjects (<3%) and likely underestimate the number of T. cruzi-specific CD8 + T cells. We believe that this minor population of the IFN-c-producing, T. cruzi-responsive cells is a more recently developed effector + T cells in chronic chagasic subjects. PBMCs were stained for CD8, CD45RA and CCR7 and analyzed by flow cytometry. Each point represents the expression of CD45RA and CCR7 on the total CD8 + T cell population for each subject. The median value for each clinical group (11 G0, 14 G1, 5 G2, 8 G3 and 13 non-infected controls) is represented by horizontal lines. *P < 0.01 versus G0 and control (analysis of variance). memory CD8
+ T cell population, as evidenced by the expression of markers of early differentiation (CD27 and CD28) and their high capacity for rapid effector function. In contrast, the bulk of the total CD8 + , antigen-experienced population appears to reflect the effects of persistent exposure to parasite antigen and is composed primarily of late-differentiated cells that are largely incapable of effector function and exhibit signs of senescence (Fig. 5) . Such late-differentiated memory CD8 + T cells, with reduced proliferation capacity and low T cell competence, have been documented in other persistent infections (20) .
The homing capacity of memory CD8 + T cells to peripheral tissues is likely to be important for the targeting of the immune response to the sites where T. cruzi localizes and replicates in the chronic stages of the disease. CD8 + T cells isolated from the muscle tissue of mice with chronic T. cruzi infections were demonstrated to express surface markers reflecting an effector/memory phenotype but have attenuated effector function (21) . In our study, we found a significantly higher level of total effector/memory CD8 + T cells (CD45RA ÿ CCR7 ÿ ) in G1 subjects relative to G0 and control subjects, and decreased levels of this subpopulation in the more severe G2 and G3 subjects. This result is interesting in that an increase in the overall effector memory is not reflected in an increase in CD8 + T cells with rapid effector response to T. cruzi-infected DCs (Fig. 1) . This observation may reflect the failure of the host immune response to control parasite replication at target tissues, concomitant with the onset of heart symptoms.
Peripheral blood T lymphocytes from subjects with indeterminate and cardiac clinical forms of chronic Chagas' disease living in endemic areas of Brazil have been shown to be 'activated', as determined by the expression of HLA-DR and CD45RA (22) (23) (24) . However, based on the expression of CD38 and Ki-67, CD8 + T cells from chronic chagasic subjects in the current study did not display a recently activated phenotype, consistent with reports for other chronic infections (11, 25) . The higher numbers of effector peripheral CD8 + T lymphocytes with lower levels of naive CD8 + T cells found in chronic chagasic subjects removed from endemic areas for longer than 20 years suggest that the immune profile in chronic chagasic subjects is independent of continuous reexposure to new infections.
In combination with our previous study, these results suggest that protection from disease associates with an increased frequency of highly competent CD8 + T cells enriched in early-differentiated cells, as observed in the subjects with no or mild disease symptoms (10; Fig. 2 and Table 2 ). Early-differentiated T cells with potent proliferation capacity have been associated with protective immunity in HIV-infected long-term non-progressors as well as in the experimental infection with Leishmania major (26, 27) . Conversely, in the face of the persistence of stimulating antigen, the overall T cell compartment is eventually driven to exhaustion, exhibits a low frequency of competent parasitespecific CD8 + T cells and predisposes the subject for disease progression. Prolonged antigen exposure during chronic parasitic, viral and bacterial infections results in the failure of memory CD8 + T cells to acquire the properties of antigenindependent memory T cells (28) (29) (30) (31) and eventual clonal exhaustion (32) (33) (34) (35) .
This model might predict that all individuals with chronic T. cruzi infection, and thus persisting antigen, will eventually suffer immune exhaustion and develop severe disease. However, the parasite load, which is influenced by both the genetics of the infecting parasites as well as the quality of the host immune response, may determine the rate at which immune exhaustion occurs, and perhaps the rate of disease progression. This model also suggests that measurement of the frequency of early-differentiated T cells may be useful in predicting which asymptomatic subjects are most likely to show progression to more severe disease. Longitudinal studies to monitor disease progression in G0 and G1 subjects with different frequencies of rapid responding early-differentiated CD8 + T cells should allow testing of this hypothesis. Finally, this model predicts that parasite load will be higher in subjects with low levels of recently differentiated effector/ memory parasite-specific CD8 + T cells. This prediction will be difficult to test as methods for the consistent quantitative assessment of parasite load in chronically infected subjects are currently unavailable.
In conclusion, our data suggest a gradual clonal exhaustion perhaps as a result of continuous antigenic stimulation by persistent parasites and associated with increased disease severity. Additional longitudinal studies of changes in CD8 + T cell sub-populations in chronically infected subjects may reveal specific markers for the propensity for progression to severe disease.
